Treatment of Syphilis with Positive RPR and Treponemal Antibodies
Immediate Treatment Recommendation
Treat with benzathine penicillin G 2.4 million units IM as a single dose if this represents primary, secondary, or early latent syphilis (acquired within the past year), or with benzathine penicillin G 2.4 million units IM weekly for 3 consecutive weeks (total 7.2 million units) if this represents late latent syphilis or syphilis of unknown duration. 1, 2
Determining the Stage of Syphilis
Before initiating treatment, you must determine the stage of infection, as this dictates the treatment regimen:
- Primary syphilis: Look for a painless ulcer or chancre at the infection site, typically present for 3-6 weeks 1
- Secondary syphilis: Examine for skin rash (often involving palms and soles), mucocutaneous lesions, or generalized lymphadenopathy, typically occurring 2-6 months after infection 1
- Early latent syphilis: No clinical manifestations, but documented infection within the past year based on seroconversion, fourfold increase in RPR titer, recent symptoms of primary/secondary syphilis, or sexual contact with a partner who has documented early syphilis 3
- Late latent or unknown duration: No clinical manifestations and cannot confirm acquisition within the past year 3, 1
- Tertiary syphilis: Assess for cardiac manifestations (aortitis), gummatous lesions, or neurologic/ophthalmic/auditory symptoms 3, 1
Treatment Regimens by Stage
Primary, Secondary, or Early Latent Syphilis
- Benzathine penicillin G 2.4 million units IM as a single dose 1, 2, 4
- This regimen has over 40 years of clinical experience with cure rates of 90-95% 1, 2
Late Latent Syphilis or Unknown Duration
- Benzathine penicillin G 2.4 million units IM weekly for 3 weeks (total 7.2 million units) 3, 1
- Cure rates are 80-85% with this extended regimen 1
Neurosyphilis (if CNS, ophthalmic, or auditory symptoms present)
- Aqueous crystalline penicillin G 18-24 million units per day IV (administered as 3-4 million units every 4 hours) for 10-14 days 3, 1
- Alternative: Procaine penicillin 2.4 million units IM once daily plus probenecid 500 mg orally four times daily for 10-14 days 3, 1
- Consider adding benzathine penicillin G 2.4 million units IM weekly for up to 3 weeks after completing neurosyphilis treatment 3, 1
Essential Concurrent Testing
- Test for HIV infection immediately in all patients with syphilis 1, 2
- HIV coinfection affects monitoring frequency and may increase risk for neurologic complications 1, 2
- If HIV-positive, use the same penicillin regimen but increase monitoring frequency 3, 1
Penicillin Allergy Management
If the patient has a documented penicillin allergy:
- For primary, secondary, or early latent syphilis: Doxycycline 100 mg orally twice daily for 14 days 3, 5
- Alternative: Tetracycline 500 mg orally four times daily for 14 days (but compliance is typically worse) 3
- For neurosyphilis or pregnancy: Penicillin desensitization is required, as no alternative agents have proven efficacy 3
- Erythromycin is less effective and should only be used when compliance can be assured 3
Follow-Up Monitoring Protocol
For Primary and Secondary Syphilis
- Clinical and serologic evaluation at 6 and 12 months after treatment using RPR or VDRL 1, 2
- Treatment success is defined as a fourfold (2 dilution) decline in nontreponemal titer within 6-12 months 1, 2
- If HIV-positive, evaluate at 3,6,9, and 12 months instead 3, 1, 2
For Latent Syphilis
- Clinical and serologic evaluation at 6,12,18, and 24 months after treatment 1
- If HIV-positive, evaluate at 3,6,9,12, and 24 months 3, 1
For Neurosyphilis
- If CSF pleocytosis was present initially, repeat CSF examination every 6 months until cell count normalizes 1
- If cell count has not decreased after 6 months or CSF is not normal after 2 years, consider retreatment 1
Treatment Failure Criteria
Treatment failure should be suspected if:
- Nontreponemal titers fail to decline fourfold within 6 months after therapy 3, 1, 2
- Clinical signs or symptoms persist or recur 3, 2
- A sustained fourfold increase in titer compared to baseline occurs 3, 2
When treatment failure occurs:
- Re-treat with benzathine penicillin G 2.4 million units IM weekly for 3 weeks 3
- Perform CSF examination to exclude neurosyphilis 3, 1
- Re-evaluate for HIV infection 3, 1
Special Populations
HIV-Infected Patients
- Use the same penicillin regimens as HIV-negative patients 3, 1
- Monitor more intensively at 3-month intervals instead of 6-month intervals 3, 1
- Consider CSF examination for late latent syphilis to exclude neurosyphilis, as HIV-infected patients have higher risk of neurologic complications 3, 1
- HIV-infected patients may have atypical serologic responses (unusually high, low, or fluctuating titers) with a prevalence of 10-20% 1, 6
Pregnant Women
- Treat with the penicillin regimen appropriate for the stage of syphilis 1
- Some experts recommend an additional dose of benzathine penicillin G 2.4 million units IM one week after the initial dose for pregnant women with primary, secondary, or early latent syphilis 1
- Treatment must occur >4 weeks before delivery for optimal outcomes 1
- If penicillin-allergic, penicillin desensitization is mandatory 3
Critical Pitfalls to Avoid
- Do not use treponemal tests (FTA-ABS, TP-PA) to monitor treatment response, as they remain positive for life and do not correlate with disease activity 3, 2
- Do not compare titers between different test types (VDRL vs RPR), as they are not directly comparable 3, 2
- Do not assume persistent low-titer reactivity indicates treatment failure, as approximately 15-25% of patients remain "serofast" with low unchanging titers despite cure 3, 1, 2
- Be aware of the prozone phenomenon, which can cause falsely nonreactive RPR results in patients with very high antibody titers, particularly in secondary syphilis or HIV-infected patients 7
- Do not use azithromycin as first-line treatment, as widespread resistance has been documented 1
- Ensure adequate follow-up, as treatment failure cannot be reliably distinguished from reinfection without serial serologic monitoring 3, 1